Cooper Companies Inc at JPMorgan Healthcare Conference Transcript
Good afternoon, everyone. I'm Robbie Marcus, the med tech analyst at JPMorgan. Very happy to introduce our next session Al White, the CEO of CooperCompanies. Al will do a 20-minute presentation, then we'll do some Q&A.
Fantastic. Thank you, Robbie. We'll jump right into it here. Our first slide, for those of you who do not know us, CooperCompanies, a leading global medical device company. We're a leader in the vision space and in the women's health, fertility, OB-GYN space. Within the vision space, we operate under CooperVision, which is about 2/3 of our revenues in the contact lens business. So we'll spend a lot of time here as we go through this presentation on the contact lens industry.
We've been a member of the S&P 500 since 2016 and recently moved to NASDAQ and now trade under NASDAQ under COO. A couple of interesting points here, just 50 million plus people benefiting from our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |